Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 221-230 of 10791

Edit search filters
  1. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis

    Rochester, MN

  2. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

    Jacksonville, FL

  3. Development of a Youth Healthy Living Program With Underserved Adolescents at Rochester Alternative Learning Center

    Rochester, MN

  4. A Study to Identify Gaps in Population Health Across the Mayo Clinic Care Network Members

    Rochester, MN

  5. A Study of Quality of Life and Pain Control Before and After Endovascular Renal Denervation in Individuals with Refractory Kidney Pain

    Rochester, MN

  6. Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation

    Rochester, MN

  7. Early Coronary Angiography Versus Delayed Coronary Angiography

    Rochester, MN

  8. A Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors that have NTRK1/2/3, ROS1, or ALK Gene Rearrangements

  9. A Study of Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure that has Preserved Ejection Fraction

    Rochester, MN, Cannon Falls, MN, La Crosse, WI, Albert Lea, MN, Austin, MN, Red Wing, MN, Mankato, MN

  10. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

    Rochester, MN

.

Mayo Clinic Footer